查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1471238

粒子治療市場：按治療類型、成分、成分、癌症類型、最終用戶 - 2024-2030 年全球預測

Particle Therapy Market by Therapy Type (Heavy Ion Therapy, Proton Therapy), Component (Product, Service), Configuration, Cancer Type, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年粒子束治療市場規模為7.7241億美元，2024年達8.315億美元，預計2030年將達到13.1887億美元，複合年成長率為7.94%。

粒子治療是更廣泛的治療技術中的一個特定部分。它主要關注粒子治療技術的全球商業化、分銷和應用。粒子療法在受控環境中使用帶電和不帶電粒子（例如質子和中子）來瞄準並消除患者體內的癌細胞。這種治療方法在確保精度方面的有效性主要推動了市場需求和成長。癌症治療中對先進治療方法的需求不斷成長，臨床試驗中擴大採用粒子束療法，快速、非侵入性且痛苦較小的手術是推動該市場成長的主要因素。另一方面，粒子束治療的保險範圍有限，並且存在與粒子束治療的輻射暴露相關的風險，這限制了其使用並阻礙了市場成長。然而，多家供應商正在開發更先進、更緊湊的粒子治療系統，專注於提高準確性並最大限度地減少潛在的副作用。此外，正在進行的質子治療研究計劃和帶電粒子治療的技術進步正在為粒子治療的擴展創造無數的機會。

主要市場統計
基準年[2023] 77241萬美元
預測年份 [2024] 8.315 億美元
預測年份 [2030] 1,318.87 百萬美元
複合年成長率（%） 7.94%

治療類型：質子療法受到消費者的青睞，因為它對周圍組織損傷的風險較低。

重粒子放射治療使用碳等高度電離的原子來精確傷害癌細胞。該技術對周圍健康組織造成的損害最小。這種治療方法對放射抗性腫瘤有效，優於傳統放射治療。質子束療法正變得越來越受歡迎，特別是在小兒科，因為它具有限制對周圍組織和器官的損害的特性，這對於腫瘤靠近重要器官的患者來說有很大的不同。重離子療法為抗輻射腫瘤提供了一種有前景的解決方案，而質子療法通常是兒童癌症患者的首選，因為它對周圍組織損傷的風險較小。

組件：組件產品的使用正在增加，因為它們在治療重要器官附近的固態腫瘤方面具有高精度。

粒子治療產品主要由以粒子束照射目標的設備組成。這包括迴旋加速器、同步迴旋加速器和同步加速器等設備。迴旋加速器用於將帶電粒子加速到高能量。同步迴旋加速器旨在透過改變加速電場的頻率來克服迴旋加速器的頻率限制。因此，它可以有效、準確地發射高能量束，使其成為粒子束治療的理想選擇。同步加速器是粒子加速器，是粒子束治療的理想選擇，因為它們可以更好地控制被加速粒子的能量。常用於治療深部腫瘤和形態複雜的腫瘤。粒子治療精確地向癌細胞提供高劑量的輻射，並且有多種系統，每種系統都提供獨特的好處，具體取決於醫療機構的特定需求和情況。服務部門包括與粒子治療系統相關的安裝、維護、培訓和諮詢服務。另一方面，癌症患者大量湧入以及支持粒子治療裝置的基礎設施的醫療機構對產品組件的需求更為迫切。在醫療機構處於開發或計劃開發粒子治療裝置早期階段的國家，對服務組件的需求較高。

配置：多房間系統可以同時治療更多患者

多室粒子束治療系統包含多個治療室，讓更多患者同時接受治療。此類系統對大型醫療設施非常有利，因為它們允許快速的患者流動、處理複雜病例的能力，並最大限度地提高粒子加速器設施的利用效率。單室系統是希望進入粒子治療領域的小型醫療機構的理想選擇。由於其緊湊的設計和相對簡單的物流，它們通常易於部署和管理。相較之下，多房間系統有利於同時治療更多患者和處理更複雜的病例，但其實施需要更高的初始投資和操作複雜性。另一方面，單室系統由於其緊湊的設計和可管理的物流而更容易安裝和操作，使其適合剛開始處理粒子治療的小型醫療機構。

癌症類型：由於降低了健康組織的風險，粒子療法在頭頸癌的應用正在擴大

粒子束療法提供高度聚焦的輻射，對於復發性和進行性乳癌患者特別有效。由於頭頸癌的解剖結構複雜，粒子治療已顯示出有希望的結果。粒子治療的精確、高劑量輻射可最大限度地降低腫瘤周圍健康組織受到過度輻射的風險。眾所周知，肺癌對傳統放射療法具有抵抗力，但粒子束療法已顯示出有希望的治療效果。粒子療法在治療兒童癌症方面也非常有效，可以減少通常與傳統放射療法相關的長期副作用。在前列腺癌的治療中，粒子束治療有效、精準的放射技術大大提高了治療效果。相較之下，粒子束療法已成為頭頸癌治療領域的新曙光，為與各種疾病作鬥爭的患者帶來了希望。

最終使用者：粒子束治療在醫院和臨床環境中發揮重要作用，以提供高品質的醫療照護。

門診手術中心 (ASC) 使外科醫生能夠以較低的成本提供高效、高品質的護理。透過粒子束療法，這些中心可以治療癌症明確且僅需要少量治療的病例。醫院和診所提供更全面的治療並治療各種癌症病例。我們提供質子和重離子療法來治療各種癌症，包括更複雜的問題。這些設施擁有大型治療設施和先進的粒子治療設備。由於其業務的性質，日間手術中心力求在有限的空間內提高效率，採用緊湊、流線型的設計，非常適合不太複雜的病例。醫院和診所提供更強大的治療能力來處理從簡單到複雜的各種病例。

區域洞察

在美國，對粒子束治療的需求不斷成長。技術創新頻繁發生，並得到私人和公共機構的大力支持。由於廣泛的研究活動和眾多投資者資助的針對治療創新的新興企業的崛起，該地區擁有最大的市場佔有率。在歐洲、中東和非洲地區，歐洲的粒子治療呈現出驚人的成長，這主要是由於各種類型癌症的發生率不斷上升以及人口老化的風險不斷增加。此外，各國政府和組織增加的醫療資金，加上醫療設施的建立，導致了這項技術的廣泛採用。中東和非洲國家也顯示出可觀的成長，這主要是由於醫療成本不斷上升以及加強醫療基礎設施的力度加大。在亞太地區，一些國家已採用粒子療法來治療癌症。促成這一進步的因素包括癌症盛行率上升、快速都市化以及經濟狀況的持續改善。亞太地區龐大的人口基數，加上醫療基礎設施的改善以及政府對癌症研究和治療的資助增加，使亞太地區成為快速成長的粒子治療市場。

FPNV定位矩陣

FPNV定位矩陣對於評估粒子治療市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限。最前線 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對粒子治療市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該細分市場競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：包括新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：包括對未來技術、研發活動和突破性產品開發的智力見解。

本報告解決了以下關鍵問題：

1.粒子束治療市場的市場規模與預測是多少？

2.在粒子束治療市場的預測期內，我們應該考慮投資哪些產品和應用？

3.粒子束治療市場的技術趨勢和法規結構是什麼？

4.粒子束治療市場主要廠商的市場佔有率為何？

5.進入粒子束治療市場的合適形式和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症治療需要先進的治療方法方法
      • 在臨床試驗中更多地採用粒子療法
      • 世界各地的粒子治療中心不斷增加
    • 抑制因素
      • 粒子治療設備和程序的成本很高，而且粒子治療的保險範圍有限。
    • 機會
      • 正在進行的質子治療調查計畫
      • 帶電粒子束治療的技術進步和個人化癌症治療策略的實現
    • 任務
      • 與粒子束治療輻射暴露相關的風險
  • 市場區隔分析
    • 治療類型：消費者更喜歡質子治療，因為對周圍組織損傷的風險較低
    • 組件：高精度增加了產品組件的使用，以治療重要器官附近的固態腫瘤
    • 配置：可以同時治療多個患者的多房間系統的可能性
    • 癌症類型：由於降低了健康組織的風險，粒子療法在頭頸癌的應用不斷擴大
    • 最終使用者：粒子治療在努力提供優質護理的醫院和醫療機構中發揮重要作用
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章粒子治療市場：依治療類型

  • 介紹
  • 重粒子線治療
  • 質子治療

第7章粒子治療市場：依組成部分

  • 介紹
  • 產品
  • 服務

第8章粒子治療市場：依成分分類

  • 介紹
  • 多房間系統
  • 單間系統

第9章粒子束治療市場：依癌症類型

  • 介紹
  • 乳癌
  • 頭頸癌
  • 肺癌
  • 兒童癌症
  • 攝護腺癌

第 10 章 粒子治療市場：依最終使用者分類

  • 介紹
  • 門診手術中心
  • 醫院/診所

第11章 美洲粒子治療市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太粒子治療市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的粒子治療市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

第15章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-335201F2E2B6

[193 Pages Report] The Particle Therapy Market size was estimated at USD 772.41 million in 2023 and expected to reach USD 831.50 million in 2024, at a CAGR 7.94% to reach USD 1,318.87 million by 2030.

The particle therapy forms a specific segment of the broader therapeutical technology. Primarily, it focuses on the global commercialization, distribution, and application of particle therapy technologies. Particle therapy utilizes charged and uncharged particles, such as protons and neutrons, within a controlled environment to target and eliminate cancer cells inside a patient's body. The effectiveness of this therapy in ensuring precision mainly drives market demand and growth. The increasing need for advanced therapies in cancer treatment and the rising adoption of particle therapy in clinical trials, fast, non-invasive, and painless procedures significantly contribute to driving this market growth. In contrast, limited insurance coverage for particle therapy and risk associated with particle therapy radiation exposure limits their utilization and penetrates the market growth. However, several vendors are developing more advanced and compact particle therapy systems and focusing on enhancing precision and minimizing potential side effects. Moreover, ongoing proton therapy research programs and technological advancements in charged-particle therapy are creating a myriad of opportunities for particle therapy expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 772.41 million
Estimated Year [2024] USD 831.50 million
Forecast Year [2030] USD 1,318.87 million
CAGR (%) 7.94%

Therapy Type: Consumer preference for proton therapy as it provides a reduced risk of damage to surrounding tissues

Heavy ion therapy employs densely ionized atoms such as carbon to initiate precise damage to cancer cells. The technique results in minimal damage to surrounding healthy tissue. This therapy is effective on radio-resistant tumors, providing an edge over traditional forms of radiotherapy. Proton therapy is increasingly preferred, especially in pediatrics, due to its damage-limiting property for surrounding tissues and organs, making a significant difference to patients with tumors near critical organs. Heavy ion therapy provides a promising solution for radio-resistant tumors, and proton therapy is often preferred for pediatric cancer patients because of its reduced risk of damage to surrounding tissues.

Component: Rising utilization of product components for treating solid tumors near vital organs due to their high accuracy

Particle therapy products primarily constitute equipment that delivers the target's particle beams. This includes machines such as cyclotrons, synchrocyclotrons, and synchrotrons. Cyclotrons are utilized to accelerate charged particles to high energies. Synchrocyclotrons are designed to overcome the frequency limitation of cyclotrons by altering the frequency of the accelerating electric field. This makes them ideal for particle therapy due to their ability to deliver high-energy beams effectively and accurately. Synchrotrons are particle accelerators but demonstrate more control over the energy of the accelerated particles, making them an excellent choice for particle therapy. They are often utilized in treating deep-seated and complex-shaped tumors. Particle therapy delivers high doses of radiation precisely to tumor cells and comes in different systems where each offers unique benefits depending upon the specific needs and situations of the healthcare establishment. The services segment includes installation, maintenance, training, and consulting services related to particle therapy systems. In comparison, the requirement for a product component is more imminent in countries with health institutes experiencing an influx of cancer patients and having the infrastructure to support a particle therapy unit. The service component's demand is more in countries where healthcare organizations are in the early stages of developing or planning to develop a particle therapy unit.

Configuration: Potential of a multi-room system for treating a larger number of patients concurrently

A multi-room system in particle therapy incorporates multiple treatment rooms, thus allowing more patients to receive treatment concurrently. These systems are immensely beneficial for large healthcare establishments, owing to the faster patient flow, the ability to treat complex cases, and the efficiency in maximizing the usage of particle accelerator facilities. Single-room systems are the ideal choice for smaller healthcare facilities that are starting to venture into the realm of particle therapy. They are generally easier to implement and manage due to the compact design and relatively simpler logistics. In comparison, multi-room systems are beneficial in treating a larger number of patients concurrently and cater to complex cases, and their implementation demands higher initial investment and operational complexity. On the contrary, single-room systems, with their compact design and manageable logistics, are easier to implement and operate, thus being a better fit for smaller healthcare facilities initiating their journey into particle therapy.

Cancer Type: Expanding usage of particle therapy for head & neck cancer owing to reduced risk on healthy tissue

Particle therapy, offering highly focused radiation, has brought about remarkable results in breast cancer management, especially for patients with recurring or aggressive forms of the disease. Particle therapy for head & neck cancer shows promising results due to the anatomical complexity of this region. The precise and high-dosage radiation from particle therapy minimizes the risk of excess radiation in healthy tissues around the tumor. Lung cancer, notorious for its resistance to traditional radiation therapy, has seen promising treatment outcomes through particle therapy. Particle therapy is considerably beneficial in treating pediatric cancers, reducing the long-term side effects usually associated with traditional radiation treatments. Prostate cancer treatment has been dramatically enhanced by particle therapy, given the highly effective and precise radiation techniques. In comparison, particle therapy has emerged as a new dawn in the field of head & neck cancer treatment, offering hope to patients battling various forms of the disease.

End-User: Significant role of particle therapy in hospitals & clinicals as they strive to provide high-quality care

Ambulatory surgery centers (ASCs) allow surgeons to deliver efficient, high-quality care at a lower cost. In particle therapy, these centers cater to instances where the cancer is well-defined and is treated in a few sessions. Hospitals and clinics offer more comprehensive care and cater to various cancer cases. They provide both proton and heavy ion therapies to treat a variety of cancers, including more complex issues. These institutions have large treatment facilities equipped with advanced particle therapy machines. Due to their nature of operation, ambulatory surgery centers embrace compact, streamlined designs best suited for less complex cases, striving for efficiency with limited space. Hospitals & clinics offer more robust treatment capabilities to manage various cases, from the simple to the complex.

Regional Insights

In America, the need for particle therapy has seen consistent growth. Technology innovation is frequent and heavily backed by both private and public organizations. This region holds the most significant market share due to extensive research activities and the rise of numerous startups funded by investors targeting therapy innovation. In the EMEA region, Europe exhibits formidable growth in particle therapy primarily due to the rising incidences of various cancer types and a growing elderly population at risk. Moreover, increased funding in healthcare from various governments and organizations, coupled with well-established healthcare facilities, allows for broader adoption of the technique. Middle Eastern and African countries also show promising growth, mainly due to rising healthcare expenditure and increased efforts to enhance healthcare infrastructure. In the APAC region, several economies are leading in adopting particle therapy for cancer treatment. Factors contributing to such progress include the increasing prevalence of cancer, rapid urbanization, and continually improving economic conditions. APAC offers a vast population base, which, combined with improving healthcare infrastructures and increasing government funding for cancer research and treatment, presents APAC as a fast-growing market for particle therapy.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Particle Therapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Particle Therapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Particle Therapy Market, highlighting leading vendors and their innovative profiles. These include Advanced Oncotherapy plc, B dot Medical Inc., Best Particle Therapy, Inc., BioSig Technologies Inc., Covenant Health, Danfysik A/S, Elekta AB, Hitachi, Ltd., IBA International, Koninklijke Philips N.V., Mevion Medical Systems, Mitsubishi Electric Corporation, New Mexico Cancer Center, Optivus Proton Therapy, Inc., P-Cure Ltd, ProTom International, Provision Healthcare, LLC, PTW Freiburg GmbH, SAH Global LLC, Shanghai APACTRON Particle Equipment Co., Ltd., Siemens Healthineers GmbH, Stantec Inc., Sumitomo Heavy Industries, Ltd., Toshiba Medical Systems Corporation, and Xstrahl Ltd..

Market Segmentation & Coverage

This research report categorizes the Particle Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Therapy Type
    • Heavy Ion Therapy
    • Proton Therapy
  • Component
    • Product
      • Cyclotrons
      • Synchrocyclotrons
      • Synchrotrons
    • Service
  • Configuration
    • Multi-room System
    • Single-room System
  • Cancer Type
    • Breast Cancer
    • Head & Neck Cancer
    • Lung Cancer
    • Pediatric Cancer
    • Prostate Cancer
  • End-User
    • Ambulatory Surgery Centers
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Particle Therapy Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Particle Therapy Market?

3. What are the technology trends and regulatory frameworks in the Particle Therapy Market?

4. What is the market share of the leading vendors in the Particle Therapy Market?

5. Which modes and strategic moves are suitable for entering the Particle Therapy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need for advanced therapies in cancer treatment
      • 5.1.1.2. Rise in adoption of particle therapy in clinical trials
      • 5.1.1.3. Growing number of particle therapy centers worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of particle therapy equipment and procedures, along with limited insurance coverage for particle therapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing proton therapy research programs
      • 5.1.3.2. Technological advances in charged-particle therapy and enabling personalized cancer treatment strategies
    • 5.1.4. Challenges
      • 5.1.4.1. Risk associated with the particle therapy radiation exposure
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Therapy Type: Consumer preference for proton therapy as it provides a reduced risk of damage to surrounding tissues
    • 5.2.2. Component: Rising utilization of product components for treating solid tumors near vital organs due to their high accuracy
    • 5.2.3. Configuration: Potential of a multi-room system for treating a larger number of patients concurrently
    • 5.2.4. Cancer Type: Expanding usage of particle therapy for head & neck cancer owing to reduced risk on healthy tissue
    • 5.2.5. End-User: Significant role of particle therapy in hospitals & clinicals as they strive to provide high-quality care
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Particle Therapy Market, by Therapy Type

  • 6.1. Introduction
  • 6.2. Heavy Ion Therapy
  • 6.3. Proton Therapy

7. Particle Therapy Market, by Component

  • 7.1. Introduction
  • 7.2. Product
  • 7.3. Service

8. Particle Therapy Market, by Configuration

  • 8.1. Introduction
  • 8.2. Multi-room System
  • 8.3. Single-room System

9. Particle Therapy Market, by Cancer Type

  • 9.1. Introduction
  • 9.2. Breast Cancer
  • 9.3. Head & Neck Cancer
  • 9.4. Lung Cancer
  • 9.5. Pediatric Cancer
  • 9.6. Prostate Cancer

10. Particle Therapy Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgery Centers
  • 10.3. Hospitals & Clinics

11. Americas Particle Therapy Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Particle Therapy Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Particle Therapy Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. IBA and PARTICLE Initiate FLASH Proton Therapy Research Partnership
    • 14.3.2. P-Cure Receives FDA Approval For Proton Therapy System For Treatment in Seated Position and Will Begin Treating Patients In Israel
    • 14.3.3. Terapet raises CHF 2.3 million for its next-generation cancer treatment technology
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. PARTICLE THERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. PARTICLE THERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PARTICLE THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PARTICLE THERAPY MARKET DYNAMICS
  • FIGURE 7. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. PARTICLE THERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. PARTICLE THERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PARTICLE THERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PARTICLE THERAPY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL PARTICLE THERAPY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL PARTICLE THERAPY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAVY ION THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROTON THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CYCLOTRONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYNCHROCYCLOTRONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYNCHROCYCLOTRONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYNCHROTRONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SYNCHROTRONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SERVICE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SERVICE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL PARTICLE THERAPY MARKET SIZE, BY MULTI-ROOM SYSTEM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL PARTICLE THERAPY MARKET SIZE, BY SINGLE-ROOM SYSTEM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL PARTICLE THERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL PARTICLE THERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PEDIATRIC CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL PARTICLE THERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL PARTICLE THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL PARTICLE THERAPY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL PARTICLE THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES PARTICLE THERAPY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 165. INDIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. INDIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 177. INDONESIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. INDONESIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 181. INDONESIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 182. INDONESIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 189. JAPAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. JAPAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. JAPAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 192. JAPAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 193. JAPAN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. JAPAN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 204. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 205. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 208. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 216. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 220. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 225. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 228. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 229. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 230. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 231. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 232. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 249. TAIWAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. TAIWAN PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. TAIWAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 252. TAIWAN PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 253. TAIWAN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. TAIWAN PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 256. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 261. THAILAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. THAILAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. THAILAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 264. THAILAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 265. THAILAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 266. THAILAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 267. THAILAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 268. THAILAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 273. VIETNAM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. VIETNAM PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. VIETNAM PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 276. VIETNAM PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 277. VIETNAM PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. VIETNAM PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 280. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA PARTICLE THERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 299. DENMARK PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. DENMARK PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. DENMARK PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 302. DENMARK PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 303. DENMARK PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. DENMARK PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. DENMARK PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 306. DENMARK PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 307. DENMARK PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. DENMARK PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 311. EGYPT PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 312. EGYPT PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 313. EGYPT PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 314. EGYPT PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 315. EGYPT PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 316. EGYPT PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 317. EGYPT PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 318. EGYPT PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 319. EGYPT PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. EGYPT PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. EGYPT PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 322. EGYPT PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 323. FINLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 324. FINLAND PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 325. FINLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 326. FINLAND PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 327. FINLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 328. FINLAND PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 329. FINLAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 330. FINLAND PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 331. FINLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 332. FINLAND PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 333. FINLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 334. FINLAND PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 335. FRANCE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 336. FRANCE PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 337. FRANCE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 338. FRANCE PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 339. FRANCE PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 340. FRANCE PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 341. FRANCE PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 342. FRANCE PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 343. FRANCE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 344. FRANCE PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 345. FRANCE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 346. FRANCE PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 347. GERMANY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 348. GERMANY PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 349. GERMANY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 350. GERMANY PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 351. GERMANY PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 352. GERMANY PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 353. GERMANY PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2018-2023 (USD MILLION)
  • TABLE 354. GERMANY PARTICLE THERAPY MARKET SIZE, BY CONFIGURATION, 2024-2030 (USD MILLION)
  • TABLE 355. GERMANY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
  • TABLE 356. GERMANY PARTICLE THERAPY MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
  • TABLE 357. GERMANY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 358. GERMANY PARTICLE THERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 359. ISRAEL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2023 (USD MILLION)
  • TABLE 360. ISRAEL PARTICLE THERAPY MARKET SIZE, BY THERAPY TYPE, 2024-2030 (USD MILLION)
  • TABLE 361. ISRAEL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 362. ISRAEL PARTICLE THERAPY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 363. ISRAEL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 364. ISRAEL PARTICLE THERAPY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLIO